Since STAT5 activation decreases apoptosis [31–34] and induces malignant transformation and tumor progression [32, 35–38], the STAT5 downregulation promoted by IRS2 inhibition may contribute to the reduced tumor proliferation and survival in HEL cells. This evidence concerns the gene IRS2 and neoplasm.